# Metabolic Effects of Betaine Supplementation

> **NCT01950039** · PHASE2 · COMPLETED · sponsor: **Joslin Diabetes Center** · enrollment: 28 (actual)

## Conditions studied

- Obesity
- Dysglycemia

## Interventions

- **DRUG:** Betaine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01950039
- **Lead sponsor:** Joslin Diabetes Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2017-12
- **Final completion:** 2018-08
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2021-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01950039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01950039, "Metabolic Effects of Betaine Supplementation". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT01950039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*